| Members |
targetComponentId |
| Thermography NOS |
Thermography (procedure) |
| Thermography NOS |
Thermography (procedure) |
| Thermomonospora formosensis |
Actinomadura formosensis (organism) |
| Thermomycolin |
Thermomycolin |
| Thiamine preparation allergy |
Allergy to thiamine (finding) |
| Thiazole dye |
Thiazole (substance) |
| Thigh flap |
Flap (substance) |
| Thigh random pattern flap |
Random pattern flap |
| Thigh sprain |
Sprain of hip |
| Thioether hydrolase |
Thioether hydrolase |
| Thiolester hydrolase |
Thiolester hydrolase |
| Thioridazine 10mg/5mL syrup |
Thioridazine 2 mg/mL oral solution |
| Thioridazine 50mg/5mL conventional release oral solution |
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Thioridazine 50mg/5mL s/f oral solution |
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Thioridazine hydrochloride 30mg/ml conventional release oral solution |
Thioridazine 30 mg/mL oral solution |
| Thioridazine hydrochloride 30mg/ml oral concentrate |
Thioridazine 30 mg/mL oral solution |
| Thiothixene hydrochloride 5mg powder for injection solution vial |
Product containing only tiotixene in parenteral dose form (medicinal product form) |
| Thiothixene hydrochloride 5mg/mL oral solution |
Tiotixene 5 mg/mL oral solution |
| Third degree atrioventricular block |
Complete atrioventricular block |
| Third degree perineal tear during delivery with postnatal problem |
Third degree perineal laceration |
| Third diphtheria and tetanus double vaccination |
Administration of third dose of diphtheria and tetanus vaccine |
| Third diphtheria and tetanus double vaccination |
Administration of third dose of diphtheria and tetanus vaccine |
| Third diphtheria, pertussis and tetanus triple vaccination |
Administration of third dose of diphtheria, pertussis, and tetanus vaccine |
| Third diphtheria, pertussis and tetanus triple vaccination |
Administration of third dose of diphtheria, pertussis, and tetanus vaccine |
| Thirst symptom |
Thirst finding |
| Thoracentesis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at the time of procedure |
Complication of procedure |
| Thoracic cage X-ray |
Plain X-ray of thoracic cage (procedure) |
| Thoracic cage X-ray |
Plain X-ray of thoracic cage (procedure) |
| Thoracic cage X-ray |
Plain X-ray of thoracic cage (procedure) |
| Thoracic discography |
Discography with injection of contrast into intervertebral disc of thoracic spine (procedure) |
| Thoracic duct operation NOS |
Thoracic duct operations |
| Thoracic duct operation NOS |
Thoracic duct operations |
| Thoracic inlet X-ray |
CT of thoracic inlet |
| Thoracic inlet X-ray |
CT of thoracic inlet |
| Thoracic inlet X-ray |
CT of thoracic inlet |
| Thoracic lymphangiogram |
Fluoroscopic lymphangiography of thoracic duct with contrast (procedure) |
| Thoracic lymphangiogram |
Fluoroscopic lymphangiography of thoracic duct with contrast (procedure) |
| Thoracic medicine service |
Pulmonary medicine service (qualifier value) |
| Thoracic mesothelioma TNM finding |
American Joint Committee on Cancer allowable value |
| Thoracic somatic dysfunction |
Somatic dysfunction of thoracic region (finding) |
| Thoracic spine X-ray |
Plain X-ray of thoracic vertebral column region (procedure) |
| Thoracoabdominal aortic aneurysm, without mention of rupture |
Thoracoabdominal aortic aneurysm |
| Thorny headed worm |
Phylum Acanthocephala (organism) |
| Thousands/microliter |
x10^3/microliter |
| Threatened abortion (antepartum) |
Threatened miscarriage |
| Threatened abortion - delivered |
Threatened miscarriage |
| Threatened abortion, unspecified as to episode of care |
Threatened miscarriage |
| Three female babies |
Number of female fetuses |
| Three female babies |
Number of female fetuses |
| Three hundred and sixty degree translocation of macula |
Translocation of retina (procedure) |
| Three male babies |
Number of male fetuses |
| Three male babies |
Number of male fetuses |
| Three previous induced terminations of pregnancy |
Past pregnancy history of multiple induced termination of pregnancy |
| Throat anti-infective preparation |
Product manufactured as oromucosal dose form (product) |
| Throat preparation |
Product manufactured as oromucosal dose form (product) |
| Thrombocytopenia NOS |
Thrombocytopenic disorder |
| Thrombocytopenia NOS |
Thrombocytopenic disorder |
| Thrombocytopenia: [congenital purpura] or [hereditary NEC] |
Hereditary thrombocytopenic disorder (disorder) |
| Thrombolytic agent |
Thrombolytic agent (substance) |
| Thrombophilia due to acquired protein C deficiency |
Acquired protein C deficiency (disorder) |
| Thrombophilia due to acquired protein S deficiency |
Acquired protein S deficiency |
| Thrombosis of renal vein |
Thrombosis of renal vein |
| Thrombosis of vein NOS |
Venous thrombosis |
| Thrombosis of vein NOS |
Venous thrombosis |
| Thrombotic microangiopathy NOS |
Thrombotic microangiopathy (disorder) |
| Thrombus due to any device, implant AND/OR graft |
Thrombosis (disorder) |
| Thumb X-ray |
Plain X-ray of thumb (procedure) |
| Thumb X-ray |
Plain X-ray of thumb (procedure) |
| Thumb X-ray |
Plain X-ray of thumb (procedure) |
| Thumb pulp flap |
Flap (substance) |
| Thymoma - category |
Thymoma |
| Thymoma, no International Classification of Diseases for Oncology subtype |
Thymoma of uncertain behaviour |
| Thymoma, type A |
Thymoma, type A, malignant |
| Thymoma, type AB |
Thymoma, type AB, malignant |
| Thymoma, type B1 |
Thymoma, type B1, malignant |
| Thymoma, type B2 |
Thymoma, type B2, malignant |
| Thymoma, type B3 |
Thymoma, type B3, malignant |
| Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial |
Product containing only thymalfasin (medicinal product) |
| Thymosin alpha 1 1.6mg powder for injection solution vial + diluent |
Product containing only thymalfasin (medicinal product) |
| Thymoxamine 0.5% conventional release eye drops |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
| Thymoxamine 0.5% preservative-free eye drops |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
| Thyroid TNM finding |
American Joint Committee on Cancer allowable value |
| Thyroid disease monitoring NOS |
Thyroid disease monitoring |
| Thyroid disease monitoring NOS |
Thyroid disease monitoring |
| Thyroid eye disease with exophthalmos |
Exophthalmos due to thyroid eye disease (disorder) |
| Thyroid eye disease with strabismus |
Exophthalmos due to thyroid eye disease (disorder) |
| Thyroid gland excision |
Thyroidectomy |
| Thyroid incision NOS |
Incision of thyroid |
| Thyroid incision NOS |
Incision of thyroid |
| Thyroid related antibody |
Thyroid antibody |
| Thyroiditis NOS |
Thyroiditis |
| Thyroiditis NOS |
Thyroiditis |
| Thyrotoxicosis NOS |
Thyrotoxicosis |
| Thyrotoxicosis NOS |
Thyrotoxicosis |
| Thyrotropin alfa 0.9mg/mL powder for injection solution vial |
Thyrotrophin only product |
| Thyrotropin alfa 1.1mg/vial powder |
Thyrotrophin only product |
| Thyroxine sodium 100micrograms tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
| Thyroxine sodium 25micrograms tablet |
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) |
| Thyroxine sodium 50micrograms tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Tibia X-ray |
Plain X-ray of tibia |
| Tic disorder unspecified |
Tic (finding) |
FHIR